In 2013, Novartis ran a project that involved virtually screening 10 million compounds against a common cancer target in less than a week. They calculated that it would take 50,000 cores and close to a $40 million investment if they wanted to run the experiment internally. Using Amazon Web Services (AWS) and the AWS Partner Network, Novartis built a platform leveraging Amazon Simple Storage Service (Amazon S3), Amazon Elastic Block Store (Amazon EBS), and four Availability Zones. The project ran across 10,600 Spot Instances (approximately 87,000 compute cores) and allowed Novartis use its 39 years of computational chemistry knowledge to conduct the experiment, which only required 9 hours and an investment of $4,232. Out of the 10 million compounds screened, three were successfully identified.

Novartis Uses AWS to Conduct 39 Years of Computational Chemistry In 9 Hours

To learn more about how AWS can help support life science needs, visit: